Renin inhibition: the next step in suppression of the renin-angiotensin system?
Azizi
Michel
M
Clinical Investigation Center 9201, Hôpital Européen Georges Pompidou, 20-40 Rue Leblanc, Paris, Cedex 15, France. michel.azizi@egp.aphp.fr
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects*; D000092502:Renin Inhibitors
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D012083:Renin; D000092502:Renin Inhibitors